Nanocarriers for Anticancer Drugs - New Trends in Nanomedicine

Author(s): Jana Drbohlavova, Jana Chomoucka, Vojtech Adam, Marketa Ryvolova, Tomas Eckschlager, Jaromir Hubalek, Rene Kizek

Journal Name: Current Drug Metabolism

Volume 14 , Issue 5 , 2013

Become EABM
Become Reviewer
Call for Editor


This review provides a brief overview of the variety of carriers employed for targeted drug delivery used in cancer therapy and summarizes advantages and disadvantages of each approach. Particularly, the attention was paid to polymeric nanocarriers, liposomes, micelles, polyethylene glycol, poly(lactic-co-glycolic acid), dendrimers, gold and magnetic nanoparticles, quantum dots, silica nanoparticles, and carbon nanotubes. Further, this paper briefly focuses on several anticancer agents (paclitaxel, docetaxel, camptothecin, doxorubicin, daunorubicin, cisplatin, curcumin, and geldanamycin) and on the influence of their combination with nanoparticulate transporters to their properties such as cytotoxicity, short life time and/or solubility.

Keywords: Nanotechnologies, nanoparticles, gene therapy, anticancer drugs, drug carriers, cancer, cytostatic, targeted therapy.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Page: [547 - 564]
Pages: 18
DOI: 10.2174/1389200211314050005
Price: $65

Article Metrics

PDF: 70